Partnership Agreement Details

QMS Medical Allied Services Limited has entered into a five-year exclusive distribution agreement with HEINE Optotechnik, a German manufacturer of primary diagnostic instruments. The agreement was signed on August 27, 2026, at HEINE headquarters in Gilching, Germany.

Agreement Terms

  • Duration: Five years, effective from January 1, 2027
  • Territory: Exclusive rights for entire India
  • Products Covered: HEINE's complete range of primary diagnostic instruments including General Medicine and ENT-Instruments, Dermatoscopes and Digital Documentation, Ophthalmic Instruments, Laryngoscopes, Loupes and Headlights, Veterinary Diagnostic Instruments, Power Sources, Bulbs, Cases, Spare parts, and special products
  • Exclusivity: HEINE shall not appoint or supply any other distributor, dealer or commercial partner for these products in India, directly or indirectly

Financial Implications

  • HEINE's current India revenue: €2.6 million (~₹30 crore) in calendar year 2026
  • Projected revenue through partnership: ₹70 crore by 2031
  • Signatories: Allan Dabreo, General Manager, Hospital & Distribution Division (QMS) and Time Martin, Chief Operations Officer (HEINE)

Strategic Significance

According to Mr. Mahesh Makhija, Chairman & Managing Director of QMS, this partnership is "central to our product business expansion strategy" and will help accelerate the company's growth trajectory over the next five years. The collaboration leverages QMS's pan-India distribution capabilities and established reputation in the Indian healthcare space.

Company Background

HEINE Optotechnik:

  • Founded: 1946
  • Headquarters: Gilching, Germany
  • Global presence: Operations in over 120 countries with subsidiaries in Australia, US, Canada, and Switzerland
  • Distribution network: 3,000 representatives, importers, and specialist dealers worldwide
  • Workforce: 500 employees
  • Ownership: Completely family-owned enterprise
  • Manufacturing: Develops and manufactures instruments at its German facilities using modern manufacturing technologies

QMS Medical Allied Services:

  • Business model: Integrated healthcare solutions company operating across healthcare products and services
  • Market position: India's only listed player with demonstrated presence in preventive healthcare management and pharma marketing segments
  • Scale: Serves more than 10 lakh patients, partnered with over 50 leading pharmaceutical and healthcare companies
  • Recent development: Migrated to NSE mainboard in June 2026
  • Growth targets: Aiming to surpass ₹500 crore revenue milestone by FY29
  • Business segments: Two growth engines – product vertical and services portfolio

Services Overview

QMS provides capabilities spanning patient engagement, Patient Service Programs (PSPs), disease management, preventive healthcare initiatives, patient screening and medical camps, healthcare staffing, and medical and diagnostic solutions. The company supports pharmaceutical companies, healthcare providers, and patients by improving patient access, enabling continuity of care, and enhancing healthcare outcomes.